Categories AlphaGraphs, Earnings, Finance

GNW Earnings: A snapshot of Genworth Financial’s Q1 2023 results

Insurance service provider Genworth Financial, Inc. (NYSE: GNW) has reported lower earnings and revenues for the first quarter of 2023. The company repurchased around $68 million of its stock during the quarter.

Genworth Financial Q1 2023 earnings infographic

Net income available to shareholders decreased to $62 million or $0.12 per share in the March quarter from $191 million or $0.37 per share in the prior-year period.

The bottom line was negatively impacted by a 2% decline in revenues to $1.85 billion. Premium revenues remained unchanged year-over-year, while net investment income rose 3%.

“Genworth’s recent achievements enable us to further refine our priorities to maximize long-term shareholder value by allocating capital from Enact, launching our CareScout services business, and stabilizing LTC through our multi-year rate action plan. As we continue to execute on our priorities, we will be well-positioned to continue returning capital to shareholders,” said Genworth’s CEO Tom McInerney.

Prior Performance

  • Genworth Financial Q4 2022 earnings infographic
  • Genworth Financial Q3 2022 earnings infographics

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top